Mannatech (NASDAQ:MTEX) Receives New Coverage from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX) in a research report sent to investors on Monday. The brokerage issued a buy rating on the stock.

Mannatech Stock Performance

Shares of Mannatech stock opened at $7.60 on Monday. The business has a 50-day moving average price of $7.39 and a two-hundred day moving average price of $7.71. Mannatech has a 1-year low of $6.75 and a 1-year high of $11.80. The company has a current ratio of 1.17, a quick ratio of 0.62 and a debt-to-equity ratio of 0.54. The company has a market cap of $14.33 million, a P/E ratio of -8.54 and a beta of 1.17.

Mannatech (NASDAQ:MTEX) last released its earnings results on Tuesday, August 13th. The company reported ($0.33) EPS for the quarter. Mannatech had a negative return on equity of 11.87% and a negative net margin of 0.97%. The business had revenue of $27.74 million for the quarter.

Insider Activity at Mannatech

In other Mannatech news, Director Larry A. Jobe sold 16,288 shares of the firm’s stock in a transaction on Monday, September 9th. The shares were sold at an average price of $7.75, for a total value of $126,232.00. Following the completion of the sale, the director now directly owns 54,721 shares in the company, valued at $424,087.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 41.50% of the stock is owned by corporate insiders.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.